With strong venture capitalists, Philadelphia has become a biotech hub for life science startups in need of accounting and audit assistance.

Putting Biotech on the Map


Perhaps not thought of in the same biotech vein as San Francisco or Boston, Philadelphia has much to offer the life science community. Steve Doneson, an EisnerAmper LLP auditor specializing in technology and life sciences, discusses the key ingredients that make up any vital hub (workforce, tax incentives, research facilities, incubators, financing) and what the City of Brotherly Love has to offer. Steve then reads the tea leaves and gives you an idea of where this burgeoning biotech hub is headed. 


Dave Plaskow: Hello and welcome to EisnerAmper’s Technology Podcast Series. With an impressive roster of biotech clients, we’re always interested in the latest industry trends and developments, as well as any related business and accounting opportunities and challenges. Today’s topic is Philadelphia as a biotech hub. I’m your host Dave Plaskow and with us today is Stephen Doneson, an auditor specializing in technology and life sciences based in EisnerAmper’s Philadelphia office. Steve, thanks and welcome to the podcast. It’s great to be here in the City of Brotherly Love.

Stephen Doneson: Nice to be with you Dave.

Stephen Doneson is an Senior Manager in the Audit and Assurance and Pension Services groups with SEC financial statement audit experience for both public and private companies in the technology, manufacturing, distribution, and insurance industries.

Contact Stephen

* Required